These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38812741)

  • 1. Integration of Multi-Omics Data for the Classification of Glioma Types and Identification of Novel Biomarkers.
    Vieira FG; Bispo R; Lopes MB
    Bioinform Biol Insights; 2024; 18():11779322241249563. PubMed ID: 38812741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma.
    Cao Y; Zhu H; Liu W; Wang L; Yin W; Tan J; Zhou Q; Xin Z; Huang H; Xie D; Zhao M; Jiang X; Peng J; Ren C
    Front Genet; 2021; 12():758596. PubMed ID: 35069679
    [No Abstract]   [Full Text] [Related]  

  • 5. DeepAutoGlioma: a deep learning autoencoder-based multi-omics data integration and classification tools for glioma subtyping.
    Munquad S; Das AB
    BioData Min; 2023 Nov; 16(1):32. PubMed ID: 37968655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
    Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
    Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Neural Network Analysis of Pathology Images With Integrated Molecular Data for Enhanced Glioma Classification and Grading.
    Pei L; Jones KA; Shboul ZA; Chen JY; Iftekharuddin KM
    Front Oncol; 2021; 11():668694. PubMed ID: 34277415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. i-Modern: Integrated multi-omics network model identifies potential therapeutic targets in glioma by deep learning with interpretability.
    Pan X; Burgman B; Wu E; Huang JH; Sahni N; Stephen Yi S
    Comput Struct Biotechnol J; 2022; 20():3511-3521. PubMed ID: 35860408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational identification and characterization of glioma candidate biomarkers through multi-omics integrative profiling.
    Liu L; Wang G; Wang L; Yu C; Li M; Song S; Hao L; Ma L; Zhang Z
    Biol Direct; 2020 Jun; 15(1):10. PubMed ID: 32539851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas.
    Powell RT; Olar A; Narang S; Rao G; Sulman E; Fuller GN; Rao A
    J Pathol Inform; 2017; 8():9. PubMed ID: 28382223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disclosing transcriptomics network-based signatures of glioma heterogeneity using sparse methods.
    Martins S; Coletti R; Lopes MB
    BioData Min; 2023 Sep; 16(1):26. PubMed ID: 37752578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics landscape of circadian rhythm pathway alterations in Glioma.
    Zhang C; Xu J; Chen L; Lin X
    Bioengineered; 2021 Dec; 12(1):3294-3308. PubMed ID: 34224318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
    Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.